Prestige Consumer Healthcare Future Growth
Future criteria checks 3/6
Prestige Consumer Healthcare is forecast to grow earnings and revenue by 34.5% and 2.1% per annum respectively. EPS is expected to grow by 34.8% per annum. Return on equity is forecast to be 10.8% in 3 years.
Key information
34.5%
Earnings growth rate
34.8%
EPS growth rate
Pharmaceuticals earnings growth | 21.4% |
Revenue growth rate | 2.1% |
Future return on equity | 10.8% |
Analyst coverage | Good |
Last updated | 08 Mar 2024 |
Recent future growth updates
Recent updates
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Mar 26An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued
Mar 05Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Feb 11Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon
Feb 05Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Dec 14Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly
Sep 10Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation
Aug 15Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?
Jun 12An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued
May 20Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors
Mar 17Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Mar 02Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price
Feb 08Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance
Feb 02Prestige Consumer Healthcare: Taking My Winnings Off The Table
Jan 19Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Nov 23Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M
Nov 03Holding Prestige Consumer Healthcare
Aug 31If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity
Aug 26We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt
Aug 05Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M
Aug 04Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?
May 27Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?
May 05Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?
Feb 22Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?
Feb 03These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively
Nov 04Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden
Aug 06Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate
Jun 14Prestige Consumer Healthcare Inc. 2021 Q4 - Results - Earnings Call Presentation
May 08These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively
Apr 19How Much Did Prestige Consumer Healthcare's (NYSE:PBH) CEO Pocket Last Year?
Feb 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 1,190 | 239 | 286 | 287 | 4 |
3/31/2025 | 1,162 | 231 | 272 | 274 | 7 |
3/31/2024 | 1,136 | 217 | 268 | 264 | 7 |
12/31/2023 | 1,134 | -81 | 232 | 241 | N/A |
9/30/2023 | 1,127 | -82 | 216 | 224 | N/A |
6/30/2023 | 1,130 | -84 | 211 | 220 | N/A |
3/31/2023 | 1,128 | -82 | 222 | 230 | N/A |
12/31/2022 | 1,109 | 210 | 225 | 234 | N/A |
9/30/2022 | 1,108 | 209 | 236 | 245 | N/A |
6/30/2022 | 1,095 | 203 | 240 | 249 | N/A |
3/31/2022 | 1,087 | 205 | 250 | 260 | N/A |
12/31/2021 | 1,058 | 189 | 245 | 256 | N/A |
9/30/2021 | 1,022 | 179 | 224 | 239 | N/A |
6/30/2021 | 983 | 179 | 209 | 230 | N/A |
3/31/2021 | 943 | 165 | 213 | 236 | N/A |
12/31/2020 | 957 | 166 | 207 | 233 | N/A |
9/30/2020 | 960 | 163 | 218 | 241 | N/A |
6/30/2020 | 960 | 152 | 222 | 240 | N/A |
3/31/2020 | 963 | 142 | 203 | 217 | N/A |
12/31/2019 | 953 | -34 | 199 | 212 | N/A |
9/30/2019 | 953 | -34 | 186 | 197 | N/A |
6/30/2019 | 954 | -36 | 176 | 186 | N/A |
3/31/2019 | 976 | -36 | 179 | 189 | N/A |
12/31/2018 | 991 | 64 | 183 | 193 | N/A |
9/30/2018 | 1,020 | 340 | 184 | 197 | N/A |
6/30/2018 | 1,039 | 340 | 199 | 212 | N/A |
3/31/2018 | 1,041 | 340 | 198 | 210 | N/A |
12/31/2017 | 1,026 | 390 | 152 | 163 | N/A |
9/30/2017 | 972 | 107 | N/A | 156 | N/A |
6/30/2017 | 929 | 109 | N/A | 151 | N/A |
3/31/2017 | 882 | 69 | N/A | 149 | N/A |
12/31/2016 | 849 | 72 | N/A | 179 | N/A |
9/30/2016 | 833 | 69 | N/A | 185 | N/A |
6/30/2016 | 824 | 68 | N/A | 182 | N/A |
3/31/2016 | 806 | 100 | N/A | 176 | N/A |
12/31/2015 | 788 | 110 | N/A | 189 | N/A |
9/30/2015 | 786 | 103 | N/A | 190 | N/A |
6/30/2015 | 761 | 88 | N/A | 170 | N/A |
3/31/2015 | 715 | 78 | N/A | 156 | N/A |
12/31/2014 | 668 | 70 | N/A | 135 | N/A |
9/30/2014 | 615 | 52 | N/A | 113 | N/A |
6/30/2014 | 601 | 69 | N/A | 118 | N/A |
3/31/2014 | 597 | 73 | N/A | 112 | N/A |
12/31/2013 | 609 | 76 | N/A | 118 | N/A |
9/30/2013 | 624 | 85 | N/A | 133 | N/A |
6/30/2013 | 619 | 72 | N/A | 146 | N/A |
3/31/2013 | 620 | 66 | N/A | 138 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PBH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: PBH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PBH is expected to become profitable in the next 3 years.
Revenue vs Market: PBH's revenue (2.1% per year) is forecast to grow slower than the US market (8.2% per year).
High Growth Revenue: PBH's revenue (2.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PBH's Return on Equity is forecast to be low in 3 years time (10.8%).